REVVITY, INC Payments to Acquire Investments
REVVITY, INC (RVTY) reported Payments to Acquire Investments of $6.30 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-27.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2024-02-27
- REVVITY, INC payments to acquire investments for the quarter ending 2023-01-01 was $2.17M, a 45.73% decline year-over-year.
- REVVITY, INC payments to acquire investments for the quarter ending 2022-10-02 was $17.77M, a 284.27% increase year-over-year.
- REVVITY, INC payments to acquire investments for the quarter ending 2022-07-03 was $4.25M, a 59.55% decline year-over-year.
- REVVITY, INC payments to acquire investments for the quarter ending 2022-04-03 was $23.00M, a 474.88% increase year-over-year.
- REVVITY, INC payments to acquire investments for fiscal 2023 was $6.30M, a 86.65% decline from fiscal 2023.
- REVVITY, INC payments to acquire investments for fiscal 2023 was $47.18M, a 103.98% increase from fiscal 2022.
- REVVITY, INC payments to acquire investments for fiscal 2022 was $23.13M, a 15.31% increase from fiscal 2021.
- REVVITY, INC payments to acquire investments for fiscal 2021 was $20.06M, a 214.06% increase from fiscal 2019.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2023-12-31 | $6.30M 10-K · filed 2024-02-27 | |||
| 2023-01-01 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $19.94M derived: sum of 2 quarters · filed 2024-02-27 | $24.19M derived: sum of 3 quarters · filed 2024-02-27 | $47.18M 10-K · filed 2024-02-27 |
| 2022-10-02 | $17.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $22.02M derived: sum of 2 quarters · filed 2022-11-14 | $45.01M 10-Q · filed 2022-11-14 | $49.01M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-07-03 | $4.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $27.25M 10-Q · filed 2022-08-09 | $31.25M derived: sum of 3 quarters · filed 2024-02-27 | $35.87M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-04-03 | $23.00M 10-Q · filed 2022-05-10 | $27.00M derived: sum of 2 quarters · filed 2024-02-27 | $31.62M derived: sum of 3 quarters · filed 2024-02-27 | $42.13M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-01-02 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $8.62M derived: sum of 2 quarters · filed 2024-02-27 | $19.13M derived: sum of 3 quarters · filed 2024-02-27 | $23.13M 10-K · filed 2024-02-27 |
| 2021-10-03 | $4.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $15.13M derived: sum of 2 quarters · filed 2022-11-14 | $19.13M 10-Q · filed 2022-11-14 | $29.63M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-07-04 | $10.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $14.51M 10-Q · filed 2022-08-09 | $25.01M derived: sum of 3 quarters · filed 2023-03-01 | $27.17M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-04-04 | $4.00M 10-Q · filed 2022-05-10 | $14.50M derived: sum of 2 quarters · filed 2023-03-01 | $16.67M derived: sum of 3 quarters · filed 2023-03-01 | $22.42M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-01-03 | $10.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $12.67M derived: sum of 2 quarters · filed 2023-03-01 | $18.42M derived: sum of 3 quarters · filed 2023-03-01 | $20.06M 10-K · filed 2023-03-01 |
| 2020-10-04 | $2.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $7.92M derived: sum of 2 quarters · filed 2021-11-09 | $9.56M 10-Q · filed 2021-11-09 | $10.56M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-07-05 | $5.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $7.39M 10-Q · filed 2021-08-10 | $8.39M derived: sum of 3 quarters · filed 2022-03-03 | $12.91M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-04-05 | $1.64M 10-Q · filed 2021-05-11 | $2.64M derived: sum of 2 quarters · filed 2022-03-03 | $7.16M derived: sum of 3 quarters · filed 2022-03-03 | $7.51M derived: sum of 4 quarters · filed 2022-03-03 |
| 2019-12-29 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $5.52M derived: sum of 2 quarters · filed 2022-03-03 | $5.87M derived: sum of 3 quarters · filed 2022-03-03 | $6.39M 10-K · filed 2022-03-03 |
| 2019-09-29 | $4.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $4.87M derived: sum of 2 quarters · filed 2020-11-10 | $5.39M 10-Q · filed 2020-11-10 | $6.91M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-06-30 | $349.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $868.00K 10-Q · filed 2020-08-11 | $2.39M derived: sum of 3 quarters · filed 2021-03-02 | $7.89M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-03-31 | $519.00K 10-Q · filed 2020-05-12 | $2.04M derived: sum of 2 quarters · filed 2021-03-02 | $7.54M derived: sum of 3 quarters · filed 2021-03-02 | $7.54M derived: sum of 4 quarters · filed 2021-03-02 |
| 2018-12-30 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $7.02M derived: sum of 2 quarters · filed 2021-03-02 | $7.02M derived: sum of 3 quarters · filed 2021-03-02 | $7.02M 10-K · filed 2021-03-02 |
| 2018-09-30 | $5.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $5.50M derived: sum of 2 quarters · filed 2019-11-05 | $5.50M 10-Q · filed 2019-11-05 | $16.28M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-07-01 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $0.00 10-Q · filed 2019-08-06 | $10.78M derived: sum of 3 quarters · filed 2020-02-25 | |
| 2018-04-01 | $0.00 10-Q · filed 2019-05-07 | $10.78M derived: sum of 2 quarters · filed 2020-02-25 | ||
| 2017-12-31 | $10.78M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $10.78M 10-K · filed 2020-02-25 | ||
| 2017-10-01 | $0.00 10-Q · filed 2018-11-06 | |||
| 2017-01-01 | $0.00 10-K · filed 2019-02-26 | |||
| 2016-01-03 | $0.00 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |